NCT07407686Not yet recruiting
Improving Engagement From Underserved Communities With Prostate Cancer Genetics Services
Improving the Engagement of Underserved Communities With the Prostate Cancer Genetics Service: Identifying Barriers & Facilitators and Developing Supportive Resources Using a Co-production and Collaborative Approach
Source: ClinicalTrials.gov · Last updated 12 Feb 2026
Brief summary (registry, in English)
Earlier work explored barriers and facilitators to accessing prostate cancer screening, particularly in underserved communities, and provided valuable insights to build upon. This study will explore perspectives on how genetic risk for prostate cancer is explained and understood through in-depth interviews with members of underserved communities. Findings from this work, alongside earlier results, will be used to co-design clear and accessible digital educational resources in collaboration with community members and relevant charities. Participation in cancer screening programmes in the UK varies, with differences linked to socioeconomic status, ethnicity and health literacy. Similar inequalities are seen in access to prostate cancer genetics services, indicating a need for improved engagement. Successful integration of genetics into prostate cancer care requires clear and inclusive information about genetic testing processes, possible outcomes and interpretation of results. Currently, there are limited resources explaining genetic risk for prostate cancer in an accessible way. Co-production with representatives from underserved communities will ensure that educational materials are understandable, relevant and acceptable to all.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 21 Nov 2025
- Start date
- 28 Feb 2026
- Primary completion date
- 31 Dec 2027
- Lead sponsor
- Royal Marsden NHS Foundation Trust
- Diseases
- Prostate cancer
- NCT number
- NCT07407686
What you commit to
- Study type: Observational
- Planned participants: 100
- From 28 Feb 2026 to the primary completion date, 31 Dec 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- To avoid exhaustion, we will only allow participation in two interview or focus groups per individual for the entirety of the study
- Those without capacity to consent to interview (capacity is assumed unless there is good reason to believe otherwise)
Who the study is looking for
- Men and people with prostates age 18 and above
- Those who belong to the three underserved groups; Black African and Black Caribbean Ancestry, transgender and non-binary people with a prostate and those with reduced access to healthcare
- We allow intersectionality within reason and will narratively describe any instances of these in the writeup of findings
- Those who are able to freely consent to inclusion
- Individuals with and without a lived experience of prostate cancer
Age in the registry: 18 years to - · Sex: Male · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.